Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-12 23:23 | 2025-08-12 | LLY | ELI LILLY & Co | Ricks David A | Director, Officer; President, Chair, and CEO | Pharmaceutical Preparations | BUY | $644.77 | 1,632 | $1,052,263 | 546,601 | +0.3% |
| 2025-01-31 03:45 | 2025-01-28 | ADBE | Adobe Inc. | Ricks David A | Director | Services-Prepackaged Software | BUY | $443.98 | 2,250 | $998,946 | 4,984 | +82.3% |
| 2022-09-28 02:28 | 2022-09-27 | ADBE | Adobe Inc. | Ricks David A | Director | Services-Prepackaged Software | BUY | $280.56 | 1,200 | $336,672 | 5,139 | +30.5% |
| 2019-10-25 19:13 | 2019-10-25 | LLY | ELI LILLY & Co | Ricks David A | Director, Officer; President & CEO | Pharmaceutical Preparations | BUY | $108.38 | 4,615 | $500,174 | 157,405 | +3.0% |
| 2018-12-22 00:02 | 2018-12-20 | ADBE | Adobe Inc. | Ricks David A | Director | Services-Prepackaged Software | BUY | $216.58 | 75 | $16,244 | 1,327 | +6.0% |
| 2018-09-26 23:31 | 2018-09-24 | ADBE | Adobe Inc. | Ricks David A | Director | Services-Prepackaged Software | BUY | $261.43 | 75 | $19,607 | 1,252 | +6.4% |
| 2016-02-03 22:04 | 2016-02-01 | LLY | ELI LILLY & Co | Ricks David A | Officer; SVP and Pres, Lilly Bio-Meds | Pharmaceutical Preparations | OPT+S | $77.66 | 5,733 | $445,228 | 79,403 | -6.7% |
| 2015-02-06 18:06 | 2015-02-04 | LLY | ELI LILLY & Co | Ricks David A | Officer; SVP and Pres, Lilly Bio-Meds | Pharmaceutical Preparations | SALE | $69.99 | 3,147 | $220,259 | 60,138 | -5.0% |
| 2015-02-04 00:08 | 2015-02-02 | LLY | ELI LILLY & Co | Ricks David A | Officer; SVP and Pres, Lilly Bio-Meds | Pharmaceutical Preparations | OPT+S | $71.51 | 4,769 | $341,031 | 63,285 | -7.0% |
| 2014-02-04 23:48 | 2014-02-03 | LLY | ELI LILLY & Co | Ricks David A | Officer; SVP and Pres, Lilly Bio-Meds | Pharmaceutical Preparations | SALE | $0.00 | 3,086 | $0 | 34,084 | -8.3% |
| 2013-02-11 23:59 | 2013-02-08 | LLY | ELI LILLY & Co | Ricks David A | Officer; SVP and Pres, Lilly Bio-Meds | Pharmaceutical Preparations | SALE | $53.91 | 3,000 | $161,730 | 26,941 | -10.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.